Skip to content

News & Events

Explore our latest news, insights, and events.

Landmark Nature Health Study Demonstrates the Effectiveness of DeepHealth’s Novel AI-Powered Breast Cancer Detection Workflow

Landmark Nature Health Study Demonstrates the Effectiveness of DeepHealth’s Novel AI-Powered Breast Cancer Detection Workflow

LOS ANGELES and SOMERVILLE, Mass., Nov. 17, 2025 (GLOBE NEWSWIRE) — RadNet, Inc. (NASDAQ: RDNT), the nation’s largest provider of outpatient diagnostic imaging services, and its wholly owned subsidiary, DeepHealth, a global leader in AI-powered health informatics, today announced results from the largest real-world analysis of AI-driven breast cancer screening ever conducted in the United States.1

GE HealthCare and RadNet’s DeepHealth Division Sign Letter of Intent to Advance Innovation and Adoption of AI-Powered Imaging Across Multiple Modalities and Remote Scanning

GE HealthCare and RadNet’s DeepHealth Division Sign Letter of Intent to Advance Innovation and Adoption of AI-Powered Imaging Across Multiple Modalities and Remote Scanning

Los Angeles – Nov. 12, 2025 – Today, GE HealthCare (Nasdaq: GEHC) and DeepHealth, Inc., a global leader in AI-powered health informatics and a wholly owned subsidiary of RadNet, Inc. (Nasdaq: RDNT), announced their intention to expand their existing strategic collaboration to further the innovation, commercialization and adoption of AI across multiple imaging modalities.

RadNet Acquires CIMAR UK, Empowering DeepHealth to Accelerate AI-Powered Imaging, Reporting and Image-Based Screening

RadNet Acquires CIMAR UK, Empowering DeepHealth to Accelerate AI-Powered Imaging, Reporting and Image-Based Screening

LOS ANGELES and LONDON, November 11, 2025 — RadNet, Inc. (NASDAQ: RDNT) (“RadNet”), a US leader in providing high-quality, cost-effective diagnostic imaging services and digital health solutions, announced today the acquisition of CIMAR UK, a leading provider of cloud-native healthcare image management solutions.

RadNet Expands Comprehensive Remote Scanning Offering with Acquisition of Alpha RT’s Assets

RadNet Expands Comprehensive Remote Scanning Offering with Acquisition of Alpha RT’s Assets

LOS ANGELES, November 5, 2025 — RadNet, Inc. (NASDAQ: RDNT) (“RadNet”), a US leader in providing high-quality, cost-effective diagnostic imaging services and digital health solutions, today announced it has acquired the assets of Alpha RT, a pioneer in remote MRI scanning solutions and services.

ESTI Winter Course 2025

ESTI Winter Course 2025

December 11-13, 2025
Helsiki, Finland
DeepHealth, a RadNet Subsidiary, Receives FDA Clearance for Remote Scanning Solution, TechLive™

DeepHealth, a RadNet Subsidiary, Receives FDA Clearance for Remote Scanning Solution, TechLive™

Somerville, MA, – August 7, 2025, DeepHealth, Inc., a wholly-owned subsidiary of RadNet, Inc. (NASDAQ: RDNT) and global leader in AI-powered health informatics, announced today that it has received FDA 510(k) clearance for TechLive™ – a remote scanning solution enabling centralized operation and supervision of MR, CT, PET/CT, and Ultrasound procedures.

RadNet’s Wholly-Owned Subsidiary, DeepHealth, Completes Acquisition of iCAD

RadNet’s Wholly-Owned Subsidiary, DeepHealth, Completes Acquisition of iCAD

Los Angeles, CA – July 17, 2025, RadNet, Inc. (NASDAQ: RDNT) (“RadNet”), a national leader in providing high-quality, cost-effective diagnostic imaging services and digital health solutions, announced today that it has completed the acquisition of iCAD, Inc. (NASDAQ: ICAD) (“iCAD”), a global leader in AI-powered breast health solutions.

RadNet, Inc. Acquires See-Mode Technologies for Innovation in AI-Powered Ultrasound Diagnostics

RadNet, Inc. Acquires See-Mode Technologies for Innovation in AI-Powered Ultrasound Diagnostics

Los Angeles, CA – June 4, 2025, RadNet, Inc. (NASDAQ: RDNT) (“RadNet”), a national leader in providing high-quality, cost-effective diagnostic imaging services and digital health solutions through its wholly-owned subsidiary DeepHealth, announced today that it has completed the acquisition of See-Mode Technologies PTE LTD (“See-Mode”), a global innovator in AI for ultrasound imaging.

33° Congresso Nazionale AINR

33° Congresso Nazionale AINR

June 11-14, 2025
Reggio Calabria, Italy | Stand 13
Visit DeepHealth at the 33rd AINR National Congress to discover our AI solutions for neuroradiology. Our team will demonstrate how our advanced algorithms enhance diagnostic accuracy and streamline workflows across neurological conditions. Experience firsthand how DeepHealth's technology integrates with existing systems to support confident, precise diagnoses. Connect with us to learn how leading Italian institutions are transforming neuroradiology practice with our AI platform. 
31st ESTI Annual Scientific Meeting

31st ESTI Annual Scientific Meeting

June 12-14, 2025
Bergen, Norway | Stand 12
Join DeepHealth at the 31st ESTI Annual Scientific Meeting to explore our AI-powered thoracic imaging solutions. With the meeting's focus on practical AI applications, discover how our advanced algorithms enhance diagnostic capabilities for lung screening. Our team will demonstrate seamless integration with existing workflows and show how leading European institutions are leveraging DeepHealth's technology to transform chest imaging and improve patient outcomes. 
13th ESUR MRI Prostate Teaching Course

13th ESUR MRI Prostate Teaching Course

June 12-14, 2025
Cambridge, UK | Stand 4
Join DeepHealth at the 13th ESUR MRI Prostate Teaching Course to discover our AI solutions for prostate imaging. With the course focusing on AI in imaging, focal therapies, and prostate cancer screening, experience how our advanced algorithms enhance and support MRI interpretation. Our team will demonstrate how DeepHealth's technology integrates with prostate imaging workflows to improve diagnostic accuracy and clinical decision-making. Connect with leading experts and see how our AI platform is advancing prostate cancer detection and management across Europe.